Skip to the page

Data / Drug companies / Dicyclomine hydrochloride

Dicyclomine hydrochloride: 50 companies and 129 products in the FDA NDC directory

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Dicyclomine hydrochloride is listed in the FDA National Drug Code Directory by 50 companies, with 129 products in commercial distribution. 129 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; capsule; injection, solution, and the newest product started marketing on September 15, 2026.

The request: Get every company that lists dicyclomine hydrochloride in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
50
Products
129
Generic (ANDA) products
129 (100.0%)
Application numbers
30
Routes
Oral, Intramuscular
Brand names
Dicyclomine
openFDA record search
api.fda.gov

Companies that list dicyclomine hydrochloride

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
NuCare Pharmaceuticals,Inc.13tablet; capsuleGeneric drugs (ANDA)November 15, 2024
A-S Medication Solutions11tablet; capsuleGeneric drugs (ANDA)November 15, 2024
Bryant Ranch Prepack8tablet; capsuleGeneric drugs (ANDA)September 13, 2023
Redpharm Drug7tablet; capsuleGeneric drugs (ANDA)May 7, 2024
Remedyrepack Inc.6tablet; capsuleGeneric drugs (ANDA)January 26, 2026
Hikma Pharmaceuticals USA Inc.4capsule; tabletGeneric drugs (ANDA)September 15, 2026
Northwind Health Company, LLC4tablet; capsuleGeneric drugs (ANDA)June 12, 2023
PD-Rx Pharmaceuticals, Inc.4tablet; capsuleGeneric drugs (ANDA)September 30, 2025
Preferred Pharmaceuticals Inc.4tablet; capsuleGeneric drugs (ANDA)August 12, 2026
Advagen Pharma Ltd3tablet; capsuleGeneric drugs (ANDA)July 17, 2026
Bryant Ranch Prepack3tablet; capsuleGeneric drugs (ANDA)May 8, 2023
Coupler LLC3capsule; tabletGeneric drugs (ANDA)April 28, 2026
PD-Rx Pharmaceuticals, Inc.3capsule; tabletGeneric drugs (ANDA)July 30, 1986
Proficient Rx LP3tablet; capsuleGeneric drugs (ANDA)February 26, 1999
St. Mary's Medical Park Pharmacy3tabletGeneric drugs (ANDA)December 30, 2024
Actavis Pharma, Inc.2capsule; tabletGeneric drugs (ANDA)July 30, 1986
American Health Packaging2tablet; capsuleGeneric drugs (ANDA)December 6, 2018
Aphena Pharma Solutions - Tennessee, LLC2capsule; tabletGeneric drugs (ANDA)February 26, 1999
Aurobindo Pharma Limited2tablet; capsuleGeneric drugs (ANDA)May 8, 2023
Camber Pharmaceuticals, Inc.2capsule; tabletGeneric drugs (ANDA)July 1, 2024
Cardinal Health 107, LLC2capsuleGeneric drugs (ANDA)October 4, 2018
Chartwell RX, LLC2capsule; tabletGeneric drugs (ANDA)February 26, 1999
Golden State Medical Supply, Inc.2tablet; capsuleGeneric drugs (ANDA)June 1, 2023
Lannett Company, Inc.2tablet; capsuleGeneric drugs (ANDA)February 26, 1999
Major Pharmaceuticals2capsule; tabletGeneric drugs (ANDA)February 26, 1999
NCS HealthCare of Ky, LLC DBA Vangard Labs2tablet; capsuleGeneric drugs (ANDA)December 14, 2022
Rising Pharma Holdings, Inc.2tablet; capsuleGeneric drugs (ANDA)June 23, 2025
Solaris Pharma Corporation2capsule; tabletGeneric drugs (ANDA)June 10, 2025
Somerset Therapeutics, LLC2injection, solutionGeneric drugs (ANDA)November 5, 2024
Upsher-Smith Laboratories, LLC2tablet; capsuleGeneric drugs (ANDA)July 1, 2023
American Regent, Inc.1injection, solutionGeneric drugs (ANDA)September 1, 2017
Ani Pharmaceuticals, Inc.1solutionGeneric drugs (ANDA)April 23, 2021
Atlantic Biologicals Corp.1solutionGeneric drugs (ANDA)March 4, 2025
AvPAK1capsuleGeneric drugs (ANDA)March 20, 2024
Bionpharma Inc.1tabletGeneric drugs (ANDA)September 13, 2023
Fosun Pharma USA Inc.1injection, solutionGeneric drugs (ANDA)December 30, 2019
Fresenius Kabi USA, LLC1injection, solutionGeneric drugs (ANDA)September 12, 2019
HF Acquisition Co LLC, DBA HealthFirst1injection, solutionGeneric drugs (ANDA)July 19, 2021
Hikma Pharmaceuticals USA Inc.1tabletGeneric drugs (ANDA)October 1, 1996
Hikma Pharmaceuticals USA Inc.1injectionGeneric drugs (ANDA)December 30, 2015
Northwind Health Company, LLC1tabletGeneric drugs (ANDA)March 6, 2026
NuCare Pharmaceuticals, Inc.1capsuleGeneric drugs (ANDA)June 19, 1986
PD-Rx Pharmaceuticals, Inc.1capsuleGeneric drugs (ANDA)June 19, 1986
Par Health USA, LLC1solutionGeneric drugs (ANDA)June 23, 2005
Proficient Rx LP1capsuleGeneric drugs (ANDA)June 19, 1986
QPharma, Inc.1capsuleGeneric drugs (ANDA)June 19, 1986
Slate Run Pharmaceuticals, LLC1injectionGeneric drugs (ANDA)September 23, 2021
Solco Healthcare US, LLC1capsuleGeneric drugs (ANDA)August 23, 2022
Trifluent Pharma, LLC1tabletGeneric drugs (ANDA)July 14, 2025
Unit Dose Solutions, Inc.1tabletGeneric drugs (ANDA)June 4, 2026

Dosage forms

Dosage formProductsShare
Tablet6751.9%
Capsule5038.8%
Injection, solution64.7%
Solution43.1%
Injection21.6%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)129100%

Pharmacologic classes

ClassProducts
Anticholinergic129

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.